Inactive Instrument

Highlights Protech Home Medical Corp Toronto S.E.

Equities

PHM

CA70324G1063

Highlights

Unlock all the news: Be the first to know and act before the market!

Quipt Home Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-15	CI
Quipt Home Medical Corp. Brief: Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue	05-15	MT
Quipt Home Medical Corp. Brief: Revenue for Q2 2024 was US$64.0 million compared to $58.1 million for Q2 2023, representing a 10% increase	05-15	MT
Quipt Home Medical Corp. announces an Equity Buyback for 3,626,845 shares, representing 8.52% for CAD 5 million.	05-02	CI
Quipt Home Medical Announces 10% Stock Buyback	05-02	MT
Quipt Home Medical Corp. authorizes a Buyback Plan.	05-01	CI
Quipt Home Medical Corp. Brief: Revenue for Q1 2024 was US$65.4 million compared to $40.8 million for Q1 2023; Net income (loss) for Q1 2024 was $(0.6) million, or ($0.01) per diluted share	02-14	MT
Quipt Home Medical Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-14	CI
Quipt Home Medical Corp. Brief: Shelf Prospectus and Registration Statement, when made final and effective, will enable Co to offer Up to C$300,000,000 of common shares, preferred shares, debt securities, warrants	12-27	MT
Quipt Home Medical Corp. Brief: Announced Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus	12-27	MT
Quipt Home Medical Corp. Up 3% In US After Hours Despite Q4 Net Loss; But Revs and Recurring Revs "Very Strong"	12-18	MT
Quipt Home Medical Corp. Brief: Adds Company "Maintains a conservative balance sheet" with net debt to Adjusted EBITDA leverage of 1.4x	12-18	MT
Quipt Home Medical Corp. Brief: Says Recurring Revenue for Q4 2023 was "Very Strong" and Exceeded 83% of total revenue, driven by growth in the Company's resupply platform	12-18	MT
Quipt Home Medical Corp. Brief: Revenue for Q4 2023 was US$62.5 million compared to $40.1 million for Q4 2022, representing a 56% increase	12-18	MT
Quipt Home Medical Corp. Brief: Net Loss for Q4 2023 was US($1.3) million, or ($0.03) per diluted share, as compared to $1.8 million, or $0.05 per diluted share for Q4 2022	12-18	MT
Quipt Home Medical Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2023	12-18	CI
Quipt Home Medical Corp. Announces Multi-State Acquisition Adding Near US$9 Million in Annualized Revenues	11/09/23	MT
Quipt Home Medical Corp. Brief: Announcing Multi-State Acquisition Adding Near US$9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration	11/09/23	MT
Quipt Home Medical Reports 64% YoY Increase in Revenue, to US$60.3 Million	14/08/23	MT
Refile-- Quipt Home Medical Brief: Revenues for fiscal Q3 2023 were US$60.3 million	14/08/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Protech Home Medical Corp Toronto S.E.

Equities

PHM

CA70324G1063

Highlights

Filters